Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, ...

When youre living with bronchiectasis, your primary goal in managing the condition is to reduce exacerbations episodes in which youre coughing, breathless, and making more phlegm and to prevent the ...

The American Thoracic Society (ATS) today announced a major quality improvement initiative aimed at tackling the persistent ...

WASHINGTON, July 1, 2025 /PRNewswire/ -- Today, on World Bronchiectasis Day, the American Lung Association is launching a new campaign to support people living with bronchiectasis, which is a chronic ...

Add Yahoo as a preferred source to see more of our stories on Google. "GMA" and sponsor Insmed explore life with a rare chronic condition that affects around 500,000 Americans, leaving them unable to ...

Results of a large, global clinical trial spanning five continents with over 1,700 patients with bronchiectasis, published this April in the New England Journal of Medicine, demonstrated benefits of ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. This study cohort was made up of 71.3% U.K. patients ...

Could this patient have an acute exacerbation of bronchiectasis? Bronchiectasis is an inflammatory disease of the airways defined by persistent respiratory symptoms (e.g., cough, sputum production, ...